Engineered bacteria carrying two anticancer components shrinks aggressive breast cancer in mice
Tumors that resist immune attack, recur, and spread pose a major challenge to cancer treatment. Because certain bacteria naturally accumulate within tumors, they serve as potential carriers for anticancer agents.
Read original article on The Medical News →